Masakazu Yashiro

14.3k total citations · 1 hit paper
364 papers, 10.9k citations indexed

About

Masakazu Yashiro is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masakazu Yashiro has authored 364 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Oncology, 142 papers in Molecular Biology and 133 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masakazu Yashiro's work include Gastric Cancer Management and Outcomes (88 papers), Cancer Cells and Metastasis (53 papers) and Genetic factors in colorectal cancer (35 papers). Masakazu Yashiro is often cited by papers focused on Gastric Cancer Management and Outcomes (88 papers), Cancer Cells and Metastasis (53 papers) and Genetic factors in colorectal cancer (35 papers). Masakazu Yashiro collaborates with scholars based in Japan, United States and United Kingdom. Masakazu Yashiro's co-authors include Kosei Hirakawa, Tasuku Matsuoka, Masaichi Ohira, Hiroaki Tanaka, Naoshi Kubo, Kazuya Muguruma, Katsunobu Sakurai, Ryosuke Amano, Michio Sowa and Takahiro Toyokawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Masakazu Yashiro

347 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomarkers of gastric cancer: Current topics and future perspective

2018 337 citations Tasuku Matsuoka, Masakazu Yashiro profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masakazu Yashiro Japan	58	5.3k	4.6k	2.6k	2.4k	2.0k	364	10.9k
Ylermi Soini Finland	59	5.8k 1.1×	3.5k 0.8×	2.7k 1.0×	2.7k 1.1×	1.5k 0.8×	283	12.2k
Hiroki Kuniyasu Japan	54	5.4k 1.0×	3.1k 0.7×	2.2k 0.8×	1.6k 0.7×	1.4k 0.7×	277	10.3k
Patrick Pauwels Belgium	60	4.3k 0.8×	4.2k 0.9×	2.9k 1.1×	3.2k 1.3×	925 0.5×	305	10.6k
Kosei Hirakawa Japan	63	4.6k 0.9×	7.6k 1.6×	3.2k 1.2×	3.3k 1.4×	3.2k 1.6×	590	14.2k
Neil A. Bhowmick United States	51	6.8k 1.3×	4.3k 0.9×	2.6k 1.0×	2.0k 0.8×	941 0.5×	144	11.4k
Dick J. Richel Netherlands	43	3.5k 0.7×	4.5k 1.0×	2.2k 0.8×	1.7k 0.7×	1.6k 0.8×	107	9.6k
Teppei Morikawa Japan	43	3.4k 0.6×	5.2k 1.1×	1.8k 0.7×	2.3k 1.0×	1.6k 0.8×	207	9.4k
Joan Albanell Spain	56	4.8k 0.9×	7.9k 1.7×	3.0k 1.1×	2.9k 1.2×	1.1k 0.6×	251	12.6k
David G. Hicks United States	49	4.4k 0.8×	6.2k 1.3×	3.9k 1.5×	1.9k 0.8×	890 0.5×	185	12.3k
Jahn M. Nesland Norway	53	5.5k 1.0×	4.5k 1.0×	2.3k 0.9×	3.0k 1.2×	1.1k 0.5×	203	11.4k

Countries citing papers authored by Masakazu Yashiro

Since Specialization

Citations

This map shows the geographic impact of Masakazu Yashiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masakazu Yashiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masakazu Yashiro more than expected).

Fields of papers citing papers by Masakazu Yashiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masakazu Yashiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masakazu Yashiro. The network helps show where Masakazu Yashiro may publish in the future.

Co-authorship network of co-authors of Masakazu Yashiro

This figure shows the co-authorship network connecting the top 25 collaborators of Masakazu Yashiro. A scholar is included among the top collaborators of Masakazu Yashiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masakazu Yashiro. Masakazu Yashiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuroda, Kenji, Yuichiro Miki, Mami Yoshii, et al.. (2025). Significance of Systemic Inflammatory Markers as Prognostic Predictors in Stage II/III Gastric Cancer Among Older Patients. Anticancer Research. 45(4). 1681–1694. 2 indexed citations

Yashiro, Masakazu, et al.. (2025). Thrombospondin-4 from cancer-associated fibroblasts downregulates ERBB2 expression in gastric cancer cells. Carcinogenesis. 46(3).

Sano, Tomoya, Takashi Sakuma, Yurie Yamamoto, et al.. (2024). Significance of Multi-Cancer Genome Profiling Testing for Breast Cancer: A Retrospective Analysis of 3326 Cases from Japan’s National Database. Genes. 15(6). 792–792. 1 indexed citations

Yashiro, Masakazu, et al.. (2022). CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells. Anticancer Research. 43(1). 25–33. 14 indexed citations

Tanaka, Masako, Masayuki Shiota, Masaru Koyama, et al.. (2020). Generation of Rat Monoclonal Antibodies Specific for Human Stromal Cell-Derived Factor-2. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 39(1). 23–26.

Sootome, Hiroshi, Hidenori Fujita, Kenjiro Ito, et al.. (2020). Futibatinib Is a Novel Irreversible FGFR 1–4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors. Cancer Research. 80(22). 4986–4997. 137 indexed citations

Yashiro, Masakazu, Tasuku Matsuoka, & Masaichi Ohira. (2018). The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models. Human Cell. 31(4). 271–281. 13 indexed citations

Tanaka, Masamitsu, Sei Kuriyama, Go Itoh, et al.. (2016). Mesothelial Cells Create a Novel Tissue Niche That Facilitates Gastric Cancer Invasion. Cancer Research. 77(3). 684–695. 33 indexed citations

Kinoshita, Haruhito, Masakazu Yashiro, Tatsunari Fukuoka, et al.. (2015). Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments. Carcinogenesis. 36(12). bgv134–bgv134. 28 indexed citations

10.

Sawada, Tetsuji, Masakazu Yashiro, Kazuhiro Sentani, et al.. (2014). New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee. Gastric Cancer. 18(1). 119–128. 26 indexed citations

11.

Aiba, Namiko, Takanori Kubo, Kazuyoshi Yanagihara, et al.. (2014). Agr2 Mediates Paracrine Effects on Stromal Fibroblasts That Promote Invasion by Gastric Signet-Ring Carcinoma Cells. Cancer Research. 75(2). 356–366. 34 indexed citations

12.

Kim, Seung Tae, Su Jin Lee, Jeeyun Lee, et al.. (2014). Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows Potent In Vitro Antitumor Activity in Gastric Cancer Cell Lines with FGFR2 Amplification. Molecular Cancer Therapeutics. 13(11). 2527–2536. 35 indexed citations

13.

Ohira, Go, Kenjiro Kimura, Nobuya Yamada, et al.. (2014). MUC1 and HER2 might be associated with invasive phenotype of intraductal papillary mucinous neoplasm.. PubMed. 60(125). 1067–72. 5 indexed citations

14.

Sato, Yuji, Masakazu Yashiro, & Nobuyuki Takakura. (2013). Heregulin induces resistance to lapatinib‐mediated growth inhibition of HER2‐amplified cancer cells. Cancer Science. 104(12). 1618–1625. 33 indexed citations

15.

Kashiwagi, Shinichiro, Masakazu Yashiro, Tsutomu Takashima, et al.. (2011). Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67. Breast Cancer Research. 13(6). R122–R122. 58 indexed citations

16.

Matsuoka, Tasuku, Masakazu Yashiro, Y. Kato, et al.. (2011). RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility. Clinical & Experimental Metastasis. 28(7). 627–636. 31 indexed citations

17.

Yagi, Yasumichi, Sachio Fushida, Shinichi Harada, et al.. (2009). Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice. Cancer Chemotherapy and Pharmacology. 66(4). 745–753. 17 indexed citations

18.

Kunii, Kaiko, Lenora J. Davis, Julie Gorenstein, et al.. (2008). FGFR2 -Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival. Cancer Research. 68(7). 2340–2348. 230 indexed citations

19.

Iwata, Caname, Mitsunobu R. Kano, Akiyoshi Komuro, et al.. (2007). Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via Reduction of Lymphangiogenesis. Cancer Research. 67(21). 10181–10189. 110 indexed citations

20.

Nakamura, Kazunori, Masakazu Yashiro, Tasuku Matsuoka, et al.. (2006). A Novel Molecular Targeting Compound as K-samII/FGF-R2 Phosphorylation Inhibitor, Ki23057, for Scirrhous Gastric Cancer. Gastroenterology. 131(5). 1530–1541. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact